Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort

ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactio...

Descripció completa

Dades bibliogràfiques

Autors principals:	Claire Moore, Andreas Halman, Tayla Stenta, Dhrita Khatri, Elizabeth Williams, Roxanne Dyas, Julian Stolper, David A. Elliott, Rachel Conyers
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-05-01
Col·lecció:	Clinical and Translational Science
Matèries:	medical oncology pediatrics pharmacogenetics pharmacogenomics precision medicine
Accés en línia:	https://doi.org/10.1111/cts.70246
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!